Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Grimaud Brett A.. Officer active across 1 company, notably Theravance Biopharma, Inc.. Aggregated, 18 reports have been recorded. Activity tracked since 20 February 2023. The latest transaction was filed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Grimaud Brett A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
7,952 shares@ US$16.950.015% mcap6.3% of flowOrdinary SharesSEC:0001966698-26-000008:0
37,500 shares0Ordinary SharesSEC:0001966698-26-000004:0
20,833 shares@ US$19.6620.2% of flowOrdinary SharesSEC:0001966698-26-000002:0
19,024 shares@ US$17.9021.5% of flowOrdinary SharesSEC:0001966698-25-000006:0
9,762 shares@ US$13.3910.4% of flowOrdinary SharesSEC:0001415889-25-022797:0
9,743 shares@ US$9.458.5% of flowOrdinary SharesSEC:0001415889-25-014259:0
75,000 shares0Ordinary SharesSEC:0001415889-25-006670:0
14,534 shares@ US$9.6614.0% of flowOrdinary SharesSEC:0001415889-25-005349:0
9,268 shares@ US$9.979.0% of flowOrdinary SharesSEC:0001415889-24-027567:0
9,268 shares@ US$8.227.1% of flowOrdinary SharesSEC:0001415889-24-022086:0
9,268 shares@ US$9.108.1% of flowOrdinary SharesSEC:0001415889-24-014135:0
100,000 shares0Ordinary SharesSEC:0001415889-24-010322:0
17,595 shares@ US$8.9215.1% of flowOrdinary SharesSEC:0001415889-24-004962:0
7,363 shares@ US$10.377.3% of flowOrdinary SharesSEC:0001415889-23-015450:0
8,912 shares@ US$9.708.2% of flowOrdinary SharesSEC:0001415889-23-012517:0
11,469 shares@ US$11.2112.4% of flowOrdinary SharesSEC:0001415889-23-008672:0
75,000 shares0Ordinary SharesSEC:0001415889-23-004273:0
10,198 shares@ US$10.4410.3% of flowOrdinary SharesSEC:0001415889-23-003071:0
About Grimaud Brett A.
Grimaud Brett A. is a declarant linked to Theravance Biopharma, Inc., where the listed role is SVP, GEN COUNSEL AND SECRETARY. The record contains 17 filings, all in the sampled set, covering the period from 2023-02-22 to 2026-04-03. The stated buy and sell amounts are 0 and 0, and the most common transaction nature is Tax withholding.